{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:54:02Z","timestamp":1794459242063,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00404-020-05696-y","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T15:03:47Z","timestamp":1596899027000},"page":"1169-1179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study"],"prefix":"10.1007","volume":"302","author":[{"given":"Mar\u00eda Victoria","family":"De Diego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"G\u00f3mez-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette Kirk","family":"Groar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"L\u00f3pez-Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mart\u00edn-Estal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-5927","authenticated-orcid":false,"given":"Inma","family":"Castilla-Cort\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Rodr\u00edguez-Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"key":"5696_CR1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ et al (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544\u2013551. https:\/\/doi.org\/10.1093\/humrep\/dep399","journal-title":"Hum Reprod"},{"key":"5696_CR2","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijerph15112589","volume":"15","author":"W Wolf","year":"2018","unstructured":"Wolf W, Wattick R, Kinkade O, Olfert M (2018) Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity. Int J Environ Res Public Health 15:2589. https:\/\/doi.org\/10.3390\/ijerph15112589","journal-title":"Int J Environ Res Public Health"},{"key":"5696_CR3","doi-asserted-by":"publisher","first-page":"96351","DOI":"10.18632\/oncotarget.19180","volume":"8","author":"T Ding","year":"2017","unstructured":"Ding T, Hardiman PJ, Petersen I et al (2017) The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget 8:96351\u201396358. https:\/\/doi.org\/10.18632\/oncotarget.19180","journal-title":"Oncotarget"},{"key":"5696_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.22034\/APJCP.2017.18.1.17","volume":"18","author":"M Bani Mohammad","year":"2017","unstructured":"Bani Mohammad M, Majdi Seghinsara A (2017) Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac J Cancer Prev 18:17\u201321. https:\/\/doi.org\/10.22034\/APJCP.2017.18.1.17","journal-title":"Asian Pac J Cancer Prev"},{"key":"5696_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000538","author":"AM Ebersole","year":"2020","unstructured":"Ebersole AM, Bonny AE (2020) Diagnosis and treatment of polycystic ovary syndrome in adolescent females. Clin Obstet Gynecol. https:\/\/doi.org\/10.1097\/GRF.0000000000000538","journal-title":"Clin Obstet Gynecol"},{"key":"5696_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219\u2013231. https:\/\/doi.org\/10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"key":"5696_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"Sirmans SM, Pate KA (2013) Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 6:1\u201313. https:\/\/doi.org\/10.2147\/CLEP.S37559","journal-title":"Clin Epidemiol"},{"key":"5696_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E et al (2015) Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 36:487\u2013525. https:\/\/doi.org\/10.1210\/er.2015-1018","journal-title":"Endocr Rev"},{"key":"5696_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-015-0762-z","volume":"14","author":"GA Aguirre","year":"2016","unstructured":"Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I (2016) Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med 14:3. https:\/\/doi.org\/10.1186\/s12967-015-0762-z","journal-title":"J Transl Med"},{"key":"5696_CR10","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.dsx.2019.06.008","volume":"13","author":"A Khorshidi","year":"2019","unstructured":"Khorshidi A, Azami M, Tardeh S, Tardeh Z (2019) The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Diabetes Metab Syndr 13:2747\u20132753. https:\/\/doi.org\/10.1016\/j.dsx.2019.06.008","journal-title":"Diabetes Metab Syndr"},{"key":"5696_CR11","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jacc.2005.11.046","volume":"47","author":"SM Grundy","year":"2006","unstructured":"Grundy SM (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093\u20131100. https:\/\/doi.org\/10.1016\/j.jacc.2005.11.046","journal-title":"J Am Coll Cardiol"},{"key":"5696_CR12","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.2337\/dc08-0423","volume":"31","author":"ES Ford","year":"2008","unstructured":"Ford ES, Li C, Sattar N (2008) Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31:1898\u20131904. https:\/\/doi.org\/10.2337\/dc08-0423","journal-title":"Diabetes Care"},{"key":"5696_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1113\/expphysiol.2006.033787","volume":"92","author":"R Wolk","year":"2007","unstructured":"Wolk R, Somers VK (2007) Sleep and the metabolic syndrome. Exp Physiol 92:67\u201378. https:\/\/doi.org\/10.1113\/expphysiol.2006.033787","journal-title":"Exp Physiol"},{"key":"5696_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1164\/ajrccm.165.5.2103001","volume":"165","author":"MSM Ip","year":"2002","unstructured":"Ip MSM, Lam B, Ng MMT et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670\u2013676. https:\/\/doi.org\/10.1164\/ajrccm.165.5.2103001","journal-title":"Am J Respir Crit Care Med"},{"key":"5696_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international. Circulation 120:1640\u20131645. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192644","journal-title":"Circulation"},{"key":"5696_CR16","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","volume":"164","author":"HJ Kim","year":"2004","unstructured":"Kim HJ, Kim HJ, Lee KE et al (2004) Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 164:2169\u20132175. https:\/\/doi.org\/10.1001\/archinte.164.19.2169","journal-title":"Arch Intern Med"},{"key":"5696_CR17","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1210\/jc.2007-0482","volume":"92","author":"A Kotronen","year":"2007","unstructured":"Kotronen A, Westerbacka J, Bergholm R et al (2007) Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 92:3490\u20133497. https:\/\/doi.org\/10.1210\/jc.2007-0482","journal-title":"J Clin Endocrinol Metab"},{"key":"5696_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.5664\/jcsm.26910","volume":"3","author":"JM Parish","year":"2007","unstructured":"Parish JM, Adam T, Facchiano L (2007) Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 3:467\u2013472","journal-title":"J Clin Sleep Med"},{"key":"5696_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ehj.2004.03.008","volume":"25","author":"AS Gami","year":"2004","unstructured":"Gami AS, Somers VK (2004) Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J 25:709\u2013711. https:\/\/doi.org\/10.1016\/j.ehj.2004.03.008","journal-title":"Eur Heart J"},{"key":"5696_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1475-2840-5-22","volume":"5","author":"A Gruber","year":"2006","unstructured":"Gruber A, Horwood F, Sithole J et al (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22. https:\/\/doi.org\/10.1186\/1475-2840-5-22","journal-title":"Cardiovasc Diabetol"},{"key":"5696_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1164\/ajrccm.165.5.2201001b","volume":"165","author":"E Tasali","year":"2002","unstructured":"Tasali E, Van Cauter E (2002) Sleep-disordered breathing and the current epidemic of obesity: consequence or contributing factor? Am J Respir Crit Care Med 165:562\u2013563. https:\/\/doi.org\/10.1164\/ajrccm.165.5.2201001b","journal-title":"Am J Respir Crit Care Med"},{"key":"5696_CR22","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/sleep\/28.10.1217","volume":"28","author":"G Cizza","year":"2005","unstructured":"Cizza G, Skarulis M, Mignot E (2005) A link between short sleep and obesity: building the evidence for causation. Sleep 28:1217\u20131220. https:\/\/doi.org\/10.1093\/sleep\/28.10.1217","journal-title":"Sleep"},{"key":"5696_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.smrv.2005.01.006","volume":"9","author":"AN Vgontzas","year":"2005","unstructured":"Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211\u2013224. https:\/\/doi.org\/10.1016\/j.smrv.2005.01.006","journal-title":"Sleep Med Rev"},{"key":"5696_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2605.2005.00623.x","volume":"29","author":"S Franks","year":"2006","unstructured":"Franks S, McCarthy MI, Hardy K (2006) Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl 29:278\u2013285. https:\/\/doi.org\/10.1111\/j.1365-2605.2005.00623.x(discussion 286-90)","journal-title":"Int J Androl"},{"issue":"20","key":"5696_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"5696_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41\u201347","journal-title":"Hum Reprod"},{"key":"5696_CR27","doi-asserted-by":"crossref","unstructured":"National Institutes of Health (2002) High Blood Cholesterol Evaluation Treatment Detection National Cholesterol Education Program Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report.","DOI":"10.1001\/jama.285.19.2486"},{"key":"5696_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/NT.0000000000000092","volume":"50","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall FQ (2015) Body mass index. Nutr Today 50:117\u2013128. https:\/\/doi.org\/10.1097\/NT.0000000000000092","journal-title":"Nutr Today"},{"key":"5696_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/09513590.2014.964201","volume":"31","author":"A La Marca","year":"2015","unstructured":"La Marca A, Grisendi V, Dondi G et al (2015) The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study. Gynecol Endocrinol 31:52\u201356. https:\/\/doi.org\/10.3109\/09513590.2014.964201","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl 5","key":"5696_CR30","first-page":"1295","volume":"13","author":"JE Nestler","year":"2000","unstructured":"Nestler JE, Jakubowicz DJ, Iuorno MJ (2000) Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome. J Pediatr Endocrinol Metab 13(Suppl 5):1295\u20131298","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5696_CR31","first-page":"105","volume":"13","author":"D Costantino","year":"2009","unstructured":"Costantino D, Minozzi G, Minozzi E, Guaraldi C (2009) Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci 13:105\u2013110","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5696_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/jcph.362","volume":"54","author":"S Dinicola","year":"2014","unstructured":"Dinicola S, Chiu TTY, Unfer V et al (2014) The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. J Clin Pharmacol 54:1079\u20131092. https:\/\/doi.org\/10.1002\/jcph.362","journal-title":"J Clin Pharmacol"},{"key":"5696_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/17512433.2014.925795","volume":"7","author":"V Unfer","year":"2014","unstructured":"Unfer V, Porcaro G (2014) Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Rev Clin Pharmacol 7:623\u2013631. https:\/\/doi.org\/10.1586\/17512433.2014.925795","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5696_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejogrb.2015.09.024","volume":"195","author":"F Facchinetti","year":"2015","unstructured":"Facchinetti F, Bizzarri M, Benvenga S et al (2015) Results from the international consensus conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology: the link between metabolic syndrome and PCOS. Eur J Obstet Gynecol Reprod Biol 195:72\u201376. https:\/\/doi.org\/10.1016\/j.ejogrb.2015.09.024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5696_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/09513590.2013.860120","volume":"30","author":"A Pizzo","year":"2014","unstructured":"Pizzo A, Lagan\u00e0 AS, Barbaro L (2014) Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol Endocrinol 30:205\u2013208. https:\/\/doi.org\/10.3109\/09513590.2013.860120","journal-title":"Gynecol Endocrinol"},{"key":"5696_CR36","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3109\/14767058.2013.766691","volume":"26","author":"B Matarrelli","year":"2013","unstructured":"Matarrelli B, Vitacolonna E, D\u2019Angelo M et al (2013) Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med 26:967\u2013972. https:\/\/doi.org\/10.3109\/14767058.2013.766691","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5696_CR37","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","volume":"340","author":"JE Nestler","year":"1999","unstructured":"Nestler JE, Jakubowicz DJ, Reamer P et al (1999) Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 340:1314\u20131320. https:\/\/doi.org\/10.1056\/NEJM199904293401703","journal-title":"N Engl J Med"},{"key":"5696_CR38","first-page":"347","volume":"11","author":"S Gerli","year":"2007","unstructured":"Gerli S, Papaleo E, Ferrari A, Di Renzo GC (2007) Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci 11:347\u2013354","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5696_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/09513590801893232","volume":"24","author":"AD Genazzani","year":"2008","unstructured":"Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM (2008) Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol 24:139\u2013144. https:\/\/doi.org\/10.1080\/09513590801893232","journal-title":"Gynecol Endocrinol"},{"key":"5696_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590.2016.1247797","volume":"33","author":"G Monastra","year":"2017","unstructured":"Monastra G, Unfer V, Harrath AH, Bizzarri M (2017) Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Gynecol Endocrinol 33:1\u20139. https:\/\/doi.org\/10.1080\/09513590.2016.1247797","journal-title":"Gynecol Endocrinol"},{"key":"5696_CR41","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.rbmo.2016.08.024","volume":"33","author":"AD Genazzani","year":"2016","unstructured":"Genazzani AD (2016) Inositol as putative integrative treatment for PCOS. Reprod Biomed Online 33:770\u2013780. https:\/\/doi.org\/10.1016\/j.rbmo.2016.08.024","journal-title":"Reprod Biomed Online"},{"key":"5696_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/09513590.2018.1540578","volume":"35","author":"F Facchinetti","year":"2019","unstructured":"Facchinetti F, Orr\u00f9 B, Grandi G, Unfer V (2019) Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials. Gynecol Endocrinol 35:198\u2013206. https:\/\/doi.org\/10.1080\/09513590.2018.1540578","journal-title":"Gynecol Endocrinol"},{"key":"5696_CR43","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.26355\/eurrev_201906_18223","volume":"23","author":"M Nordio","year":"2019","unstructured":"Nordio M, Basciani S, Camajani E (2019) The 40:1 myo-inositol\/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci 23:5512\u20135521. https:\/\/doi.org\/10.26355\/eurrev_201906_18223","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5696_CR44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.tem.2018.09.001","volume":"29","author":"AS Lagan\u00e0","year":"2018","unstructured":"Lagan\u00e0 AS, Garzon S, Casarin J et al (2018) Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends Endocrinol Metab 29:768\u2013780. https:\/\/doi.org\/10.1016\/j.tem.2018.09.001","journal-title":"Trends Endocrinol Metab"},{"key":"5696_CR45","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/aogs.13395","volume":"97","author":"T Tanbo","year":"2018","unstructured":"Tanbo T, Mellembakken J, Bjercke S et al (2018) Ovulation induction in polycystic ovary syndrome. Acta Obstet Gynecol Scand 97:1162\u20131167. https:\/\/doi.org\/10.1111\/aogs.13395","journal-title":"Acta Obstet Gynecol Scand"},{"key":"5696_CR46","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/humrep\/deaa069","volume":"35","author":"Y He","year":"2020","unstructured":"He Y, Tian J, Blizzard L et al (2020) Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the childhood determinants of adult health study and the bogalusa heart study. Hum Reprod 35:1185\u20131198. https:\/\/doi.org\/10.1093\/humrep\/deaa069","journal-title":"Hum Reprod"},{"key":"5696_CR47","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa285","author":"H Cena","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE (2020) Obesity, polycystic ovary syndrome and infertility: a new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa285","journal-title":"J Clin Endocrinol Metab"},{"key":"5696_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1471-0528.1992.tb14470.x","volume":"99","author":"D Hamilton-Fairley","year":"1992","unstructured":"Hamilton-Fairley D, Kiddy D, Watson H et al (1992) Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol 99:128\u2013131. https:\/\/doi.org\/10.1111\/j.1471-0528.1992.tb14470.x","journal-title":"Br J Obstet Gynaecol"},{"key":"5696_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1210\/jcem-68-1-173","volume":"68","author":"R Pasquali","year":"1989","unstructured":"Pasquali R, Antenucci D, Casimirri F et al (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 68:173\u2013179. https:\/\/doi.org\/10.1210\/jcem-68-1-173","journal-title":"J Clin Endocrinol Metab"},{"key":"5696_CR50","first-page":"37","volume":"40","author":"N Naderpoor","year":"2015","unstructured":"Naderpoor N, Shorakae S, Joham A et al (2015) Obesity and polycystic ovary syndrome. Minerva Endocrinol 40:37\u201351","journal-title":"Minerva Endocrinol"},{"key":"5696_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-020-00210-0","author":"HH Loh","year":"2020","unstructured":"Loh HH, Yee A, Loh HS et al (2020) Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis. Hormones (Athens). https:\/\/doi.org\/10.1007\/s42000-020-00210-0","journal-title":"Hormones (Athens)"},{"key":"5696_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-1792-1_8","author":"A Woodward","year":"2020","unstructured":"Woodward A, Klonizakis M, Broom D (2020) Exercise and polycystic ovary syndrome. Adv Exp Med Biol. https:\/\/doi.org\/10.1007\/978-981-15-1792-1_8","journal-title":"Adv Exp Med Biol"},{"key":"5696_CR53","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0173","author":"Z Javed","year":"2020","unstructured":"Javed Z, Papageorgiou M, Madden LA et al (2020) The effects of empagliflozin versus metformin on endothelial microparticles in overweight\/obese women with polycystic ovary syndrome. Endocr Connect. https:\/\/doi.org\/10.1530\/EC-20-0173","journal-title":"Endocr Connect"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05696-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T23:19:43Z","timestamp":1628378383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05696-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5696"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05696-y","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,8]]},"assertion":[{"value":"5 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the \u201cFundaci\u00f3n de Investigaci\u00f3n HM Hospitales de Madrid\u201d (14.11.704-GHM).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}